APT Medical Inc - Asset Resilience Ratio
APT Medical Inc (688617) has an Asset Resilience Ratio of 11.04% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688617 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how APT Medical Inc's Asset Resilience Ratio has changed over time. See APT Medical Inc (688617) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down APT Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of APT Medical Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥382.17 Million | 11.04% |
| Total Liquid Assets | CN¥382.17 Million | 11.04% |
Asset Resilience Insights
- Moderate Liquidity: APT Medical Inc has 11.04% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
APT Medical Inc Industry Peers by Asset Resilience Ratio
Compare APT Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for APT Medical Inc (2021–2023)
The table below shows the annual Asset Resilience Ratio data for APT Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 2.33% | CN¥60.00 Million ≈ $8.78 Million |
CN¥2.57 Billion ≈ $376.51 Million |
-37.26pp |
| 2022-12-31 | 39.59% | CN¥881.34 Million ≈ $128.97 Million |
CN¥2.23 Billion ≈ $325.73 Million |
-5.80pp |
| 2021-12-31 | 45.39% | CN¥913.72 Million ≈ $133.71 Million |
CN¥2.01 Billion ≈ $294.58 Million |
-- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more